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The rising global burden of chronic non-communicable diseases (NCDs) has put a strain on 
healthcare systems globally, especially in low- and middle-income countries, which have seen 
disproportionate mortality rates due to non-communicable diseases. These deaths are in part 
due to challenges with medication adherence, which are compounded by lack of access to medi-
cation and weak community support systems. This paper aims to propose a potential solution 
using models of service delivery in HIV/AIDS, given the many similarities between NCD and HIV/
AIDS. Models that have been particularly effective in HIV/AIDS are the community-based peer-
support medication delivery groups: medication adherence clubs and community antiretroviral 
therapy (ART) groups. The positive outcomes from these models, including improved medication 
adherence and patient satisfaction, provide evidence for their potential success when applied to 
non-communicable diseases, particularly hypertension and cardiovascular disease. 
Keywords: non-communicable diseases; adherence clubs; medication adherence; community 
models of care
Introduction
Currently, healthcare systems are learning to adapt to a shifting disease landscape, in which the burden of 
communicable diseases is decreasing while, simultaneously, the global burden of non-communicable dis-
eases (NCD) is rising [1]. In 2016, NCDs were responsible for 71% of the world’s 57 million deaths. Of those, 
15 million deaths were premature, occurring in people aged between 30-70 years [1]. While this is a global 
problem, low- and middle-income countries (LMIC) are disproportionately affected, accounting for 78% of 
all NCD deaths [1]. The reasons for this high mortality rate include lack of access to medical care and lack of 
affordability of recommended medications, as well as medication non-adherence, a problem which is more 
prevalent in LMICs than high-income countries [2]. One demonstration of this problem in the management 
of atherosclerotic cardiovascular diseases (CVD), which is the leading cause of death among NCDs, was 
detailed in the PURE study. The PURE study showed that the use of cardiovascular preventive medications 
(statins, antiplatelets and blood pressure lowering drugs) tends to decrease in line with a decrease in the 
country’s income level [3]. In low-income countries, less than 10% of participants, all of whom had a history 
of heart disease or stroke, were taking the four major cardiovascular secondary prevention drugs [3]. There 
was also high variation between urban and rural areas for LMICs, with those in urban areas having higher 
treatment coverage rates, showing that access is a significant part of the problem [3]. Whether it is due to 
lack of access, lack of availability, or human error (such as forgetfulness), when patients do not adhere to 
their preventive medications, there is an associated two-fold increase in the rate of CVD events compared 
to those who are adherent [4]. Therefore, cost-effective, scalable solutions are needed to improve access and 
adherence to recommended CVD preventive medications in LMIC in order to reduce complications related 
to CVD, and thus the burden on the healthcare systems. 
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Many of the same healthcare systems that are now dealing with this rising prevalence of CVD, including 
risk factors such as diabetes and hypertension, and the need to improve medication adherence to preventive 
medications, have already put in healthcare structures to deal with the parallel crisis of HIV/AIDS, leading 
to significant interest in leveraging this infrastructure to help manage the rising burden of CVD as well [5]. 
This is true for many countries in sub-Saharan Africa, which have the highest age-standardized mortality 
rates for both HIV/AIDS and NCDs [5]. In this geographical area, HIV/AIDS management has improved in 
the last two decades and now the percentage of people accessing anti-retroviral therapy (ART) is over 50% 
[6]. On the other hand, only 10% of patients with established CVD are taking medication in low-income 
countries [3] with similarly low rates for CVD risk factors, such as hypertension [7]. These data show that 
the success in improving access to HIV/AIDS medications has not yet been transferred to NCD. Besides the 
double burden of HIV/AIDS and NCD in sub-Saharan Africa, there are many shared barriers to care in these 
two diseases contexts. Both HIV/AIDS and CVD requires consistent medication regimes; ongoing, lifelong 
access to primary health care; healthy living and self-management, including high adherence to continued 
self-monitoring and to medications. In addition to patient-level barriers, the continued management of 
HIV/AIDS as well as CVD patients places a large economic burden on the clinics that must support them 
[5]. To address these latter concerns, there is evidence that decentralizing clinical service and moving care 
from facilities into the community would decrease the clinics’ costs [6]. Effective community-based inter-
ventions have already been developed and evaluated for HIV/AIDS. One such effective intervention is the 
community-based medication delivery strategy that relies on a club or group setting to deliver the medica-
tions to the patients and promote adherence. These community-based medication delivery strategies have 
been shown to have statistically significant increases in retention in care, lower costs, and shorter waiting 
times in clinics involved in the management of HIV/AIDS patients [8].
The aim of this paper is to present a hypothesis generating narrative review of the literature to describe 
the factors that led to the success of these community-based medication delivery strategies at national 
healthcare system, clinic, and patient levels in the HIV/AIDS setting, and to discuss whether such interven-
tions may be transferable to the CVD setting in LMIC, specifically in patients with conditions that are ame-
nable to decentralized management in the community including stable patients with coronary heart disease 
or stroke, or risk factors such as hypertension and diabetes.
Methods
We used a hierarchical search strategy to identify relevant articles related specifically to medication delivery/
adherence clubs involving club or group settings, including:
1. Pubmed search including the following search terms: ‘medication adherence clubs,’ ‘community ART 
groups AND HIV/AIDS,’ and ‘community health service delivery AND (non-communicable OR chronic) 
diseases.’
2. Searching the reference lists of identified articles from the pubmed search.
3. Discussion with experts currently working in this area to identify any articles that may have been missed.
Identified articles were collated and data was extracted on program elements, efficacy data, and any descrip-
tion around factors that facilitated effectiveness and sustainability of these programs. Results were collated 
and summarized for key themes and messages and evaluated for applicability to the management of stable 
cardiovascular disease and its risk factors.
Results
Eighteen articles of relevance were identified, covering six countries. Many studies were closely linked to 
each other in evaluating the same program, or in evaluating programs that were established as a result of the 
successful implementation of a similar program elsewhere. A summary of the studies and their connections 
to each other is provided below.
South Africa
•	 Retrospective cohort study [8] with associated health economic analysis [9] of a pilot program in 
Khayelitsha, South Africa, evaluating effectiveness and cost-effectiveness of the pilot program.
•	 Retrospective cohort study [10] in the Western Cape, South Africa (scaleup of the pilot study in 
Khayelitsha), evaluating effectiveness of the scaleup program.
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•	 Analytical cross-sectional study [11] in Eden, South Africa (part of Western Cape scaleup), evaluat-
ing patients’ satisfaction with adherence clubs and relationship to treatment adehrence.
•	 Qualitative study [12] in Khayelitsha and Gugulethu, South Africa (part of the Western Cape 
scaleup), exploring patients’ experiences with adherence clubs.
•	 Five papers outlining a broad program of realist theory testing case studies [13–17] in Western 
Cape, South Africa, evaluating how and why adherence clubs work.
•	 A scoping review [18] of sustainability factors of the scaleup of medication clubs in the Western 
Cape.
Mozambique
•	 A cohort study in Tete, Mozambique [19], with an associated qualitative study [20].
Malawi
•	 A qualitative study in Thyolo, Malawi [21], evaluating benefits and limitations of comunity ART 
groups (this program grew out of the successful program implemented in Tete, Mozambique).
Zimbabwe
•	 A qualitative study in Zimbabwe [22], evaluating the perceived effects of community ART refill 
groups (this program grew out of the successful program implemented in Tete, Mozambique).
Haiti
•	 Descriptive case study [23] of an adapted community ART group model in Haiti (this program was 
based on the successful program implemented in Tete, Mozambique).
Kenya
•	 Retrospective descriptive study [24] in Kibera, Kenya (this program trialled expansion of the club 
model from South Africa to include a mixed chronic disease population).
•	 Qualitative study [25] evaluating the acceptability of integrated medication adherence clubs in 
Kibera, Kenya.
Sub-saharan Africa
•	 A review article of community-based models for HIV healthcare delivery in South Africa, Demo-
cratic Republic of Congo, Malawi, and Mozambique (this paper summarised results from several 
other papers)
Community-Based Medication Delivery Strategies in HIV/AIDS
Broader community-based medication delivery strategies in HIV/AIDS may include a variety of initiatives, 
including medical appointment spacing and fast-track drug refilling, community antiretroviral therapy 
(ART) distribution points, medication adherence clubs (MACs), and community ART groups (CAGs) [26], 
with the last two approaches being of key interest to this paper. All these strategies target stable patients 
who have a degree of immune recovery or are virologically suppressed, aiming to decentralize care and 
separate the dispensing of ART refills from clinical consultation. This decentralization allows patients to 
access their medications without having to make frequent long trips to the clinic and wait long hours for a 
clinical evaluation and to collect the medication. In addition to easier access to the medication, community 
ART groups (CAGs), and medication adherence clubs (MACs) are unique for having an element of adher-
ence support from peers. There are some key differences between these two approaches. CAGs are patient-
led, and group members take turns picking up and distributing the medication, and the group provides 
adherence support and monitors treatment outcomes. Clinical consultation for members occurs either 
as a group in-clinic or when members need refills. MACs are led by a lay health worker or peer counselor, 
who distributes medications and monitors symptoms, as well as providing peer support when distributing 
medication [26]. In terms of implementation, it is important to consider the community’s human resources 
before deciding between these two approaches. Beyond that, these two approaches function similarly and 
have similar positive outcomes, with the shared goal of these groups being to improve adherence to medi-
cations by reducing burdens for patients and the healthcare system, increase retention in care, and lower 
service-provider costs.
Kwon et al: Community Group-Based Models of Medication DeliveryArt. 36, page 4 of 8
Effectiveness of Community-Based Medication Delivery Clubs/Groups
The two key programs were those from South Africa and Mozambique, with other projects utilizing the suc-
cesses of these programs to establish their own programs. Two papers reported lower mortality rates with 
both MACs and CAGs in both South Africa and Mozambique, respectively [8, 19], as well as greater retention 
in care, lower costs to the clinic [9, 19], and higher patient satisfaction (see Table 1 for summarized data 
from these programs) [11]. The success of these initial programs has led to national scale-up in both South 
Africa and Mozambique, with 18,000 patients in South Africa and 17,000 in Mozambique being treated with 
these approaches in 2014 [27]. In qualitative studies, patients were satisfied with the club model, especially 
in regard to their peer support and time-saving qualities [12, 20–21].
The Mozambique program in particular inspired two similar programs to be implemented in Southern 
Haiti and Zimbabwe [22–23]. Both of these programs have reported high rates of satisfaction from both 
patients and care providers, and have empowered patients in their own HIV care [22, 23].
Sustainability Factors 
The success of these clubs shows the strength of community-based care. However, in addition to the effec-
tive structure, there are external factors that influence the success of the program (Figure 1). These factors 
exist at macro, meso, and micro (i.e., national, community, and patient) levels, but each level affects the oth-
Table 1: Summarized Outcomes of Medication Adherence Clubs and Community ART Groups.
Medication Adherence Clubs Community ART Groups
Country South Africa Mozambique
Study Design Cohort analysis and comparison club care vs. 
usual care
Retrospective cohort study (survival analysis)
Duration of follow-up 
(median per person)
39 months [38–39] for those study 
participants (n = 502)
19 months [10–29] (n = 5729)
Mortality <1% at 40 months 2.1 per 100 person-years
Loss to follow-up 2.8% at 40 months 0.1 per 100 person-years
Retention in care in 
program*
97% at 40 months in club (n = 502) vs. 85% 
in usual care (n = 2327)
97.7% at 12 months, 96.0% at 24 months, 
93.4% at 36 months, 91.8% at 48 months
Cost per patient $58 p/patient year in club vs. $109 in usual 
care
49.6% reduction of clinic visits with reduc-
tion of 62% in ART refill visits
Patients currently 
enrolled (% active ART 
cohort)
5909 (23%)
Roll-out in Cape Town (Western Cape): 
18,719—19% of overall ART cohort (98,233)
8181 (50%) 
17,272 patients in CAGs country wide (Octo-
ber 2013)
* Retention in care: total number of patients on ART care followed in the program (excluding those who are transferred 
out).
Table adapted from Bemelmans et al. (2014).
Figure 1: Groups of Sustainability Factors.
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ers in multi-faceted ways. One essential aspect when considering implementation of these clubs is a national 
drug system that can consistently supply medicines to patients [28]. Of note, medication for HIV/AIDS is 
often provided for free in donor-led programs, which may not be the case for other diseases. Therefore, 
generalizability of the success of these clubs—when patients need to pay for medications—is unclear. Also, 
there must be a national buy-in from policy makers, even before scale-up, to aid implementation and help 
support the drug system. For this national buy-in to be in place, it is essential to ensure that these clubs are 
socially acceptable and built on cultural values and structures. On a community level, an active conversa-
tion between the clinic and the club is essential in ensuring that there are bilateral referrals. Patients must 
be able to fluidly move between clinic and club as their conditions worsen or improve [14, 18]. There also 
must be a network of community health workers in place. For MACs, they are needed to run the clubs and 
ensure proper education. The burden for CAGs is less, as these are patient-led clubs; however, community 
health workers are often still necessary to train the participants in proper adherence and check-up behavior 
[12]. Finally, the physical space of the club, whether it be in the community or in a clinic space, should be 
comfortable and free of stigma for the patients. The club space directly impacts on the patient-level factor, 
as patients must feel comfortable in the club by being surrounded by peers with similar disease contexts, 
and peer leaders who are empathic to their needs [14, 18]. In addition, it is also important to ensure that 
the medical criteria for patients under consideration for entry into the club is not so strict that it ultimately 
excludes most community members [12].
Applicability to Non-Communicable Diseases
These sustainability factors provide a framework when considering how the HIV/AIDS club model can be 
applied to NCD, especially CVD, given the high degree of similarity between these two epidemics. Many 
of the barriers to ART adherence also apply to CVD medication adherence, particularly those barriers that 
MACs and CAGs address. These include drug supply/procurement, referrals and linkages, community 
involvement, and importantly, lack of adherence support. Because of all these shared similarities in barriers 
to care, the medication delivery club model in place for HIV/AIDS could help address many of those bar-
riers in CVD [5]. Not only are the barriers and challenges similar, but in the places where HIV/AIDS clubs 
are already in place, the resources and structures are already functional and effective [29]. For example, a 
wide network of community health workers already trained in HIV/AIDS club management could readily 
be trained in CVD club management, and thus a potential sustainability factor is already more accessible. 
Therefore, the external factors that contributed to the success of HIV/AIDS medication delivery clubs would 
also aid the success of potential NCD-focused clubs, and thus should be considered when interventions are 
being developed. 
Feasibility challenges
However, there are also several factors that differ between the context of HIV/AIDS and management of ath-
erosclerotic CVD and its risk factors, which may impact the likely transferability of this effectiveness. Firstly, 
there is significant global investment from donor agencies in the management of HIV/AIDS, which is largely 
responsible for the successful coverage of ART via provision of free drugs. Despite growing acknowledge-
ment of the epidemic of CVD (amongst other NCDs) similar interest and investment has not yet occurred, 
meaning that the majority of patients in LMIC must pay for CVD medications out of pocket. Additionally, 
untreated HIV rapidly becomes symptomatic, which is likely to positively impact patients’ likelihood of tak-
ing medication, whereas hypertension or uncontrolled diabetes may well be asymptomatic. Even if a patient 
has already had a heart attack or stroke, they may think they are now ‘cured’ because they are out of the 
hospital, and therefore not prioritize all the medications they are prescribed. Additionally, due to extensive 
education programs over the last few decades, awareness of HIV/AIDS is high amongst highly prevalent 
countries, with commensurate awareness still lacking around NCDs. However, this last point may actually 
argue in favor of peer support clubs to improve support and education for such patients.
Clinic-based integrated care delivery
There is some evidence that clinic-based approaches that adapt or integrate the care of patients with NCD 
into already existing structures for patients with HIV/AIDS are effective. In Ethiopia, an HIV/AIDS clinic 
adapted registers, charts, flow sheets, and training of community health workers and peer educators for 
diabetes, leading to an increase in quality of care after six months for patients with diabetes [5]. In Cambo-
dia, MSF and the government piloted two ‘chronic disease clinics’ (as opposed to disease specific clinics) for 
integrated care for HIV, diabetes, and hypertension, which led to high rates of retention for all the diseases—
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between 70%–90% [5]. Even though these are clinic-based interventions, rather than community-based, it 
demonstrates feasibility of the concept.
Community-based integrated medication adherence clubs (HIV/AIDS+)
To date, there is one relevant case study, conducted in Kibera, Kenya, where integrated care was applied to 
medication adherence clubs in a LMIC. This adherence club integrated hypertension, diabetes mellitus, and/
or HIV/AIDS patients [24]. A total of 2,208 consultations originally done in the clinic were done in the com-
munity, saving the clinic the burden of routine check-ups and refills in terms of both time and money [24]. 
Only 2% of the patients required referral back to the clinic due to worsening of the health condition, and 
only 3.5% were lost to follow-up [24], showing the success of these clubs when simple medication processes 
were shifted to the community. A qualitative study of this same intervention found that the overall accept-
ability of the club was high and that many patients perceived clear benefits from it, including time-saving 
qualities, convenience, and peer support [25]. 
In the Kenya study, stigmatization was not found as a barrier to adherence for club members. However, 
stigma towards diseases can vary widely, with diseases such as HIV/AIDS and diabetes facing higher amounts 
of discrimination than CVD [5]. Furthermore, there is some evidence that integrated care may lead to dis-
comfort of patients, if they are treated with patients whose diseases differ from their own [13]. In general, 
these clubs fulfill their function best if the patients feel as though they can relate to each other’s experiences 
and lifestyles. This feeling of comfort could potentially be hindered by patients with varying diseases being 
integrated into one club.
Community-based clubs for cardiovascular disease (or risk factors)
A recent paper reported the implementation of a community peer-support group that is solely focused on 
adherence to antihypertensive medication, and is looking to show the feasibility of adapting either MAC or 
CAG approaches, depending on the context, to the NCD setting. However, results as to its success or other-
wise are not yet available [30].
Overall, although there are promising reports, there is a lack of sufficient evidence as yet that MACs and 
CAGs are readily transferable to the CVD (or any other NCD) setting, and like all interventions, context is key; 
such clubs may work in some areas and not others.
Recommendations
Given the many similarities between NCD and HIV/AIDS treatment and barriers to adherence, there is evidence 
that effective community-based care interventions in HIV/AIDS may be feasible to be delivered to patients 
with NCD. A particularly successful model in HIV/AIDS has been community-based medication delivery clubs/
groups, which not only provide medication and routine check-ups at more convenient times and places to the 
patients, but also provide additional peer support. These community-based medication delivery clubs/groups 
have been shown to increase retention, lower loss to follow up, decrease mortality, and cost significantly less 
than traditional services delivered within the clinic setting. Promising results have also been reported with 
integrated care, where patients with diabetes and hypertension and those with HIV/AIDS are managed in the 
same settings, be it a clinic or community setting. However, there is also evidence that single-disease clubs are 
more ideal, due to patients being more comfortable within a group of people with similar lived experiences.
Based on the findings discussed in this paper, there is potential for community-based medication deliv-
ery clubs/groups—which are ideally solely focused on supporting people with NCD—to improve outcomes, 
similar to what has happened in the HIV/AIDS context. Implementing more community-based healthcare 
models, such as the community-based medication delivery clubs/groups, for different disease areas may, 
therefore, help to decrease the strain on healthcare systems in LMIC, which will be particularly impactful 
given the high prevalence of NCD in these countries. Additional research is needed to demonstrate this pre-
dicted benefit and any additional sustainability factors needed in the NCD context. 
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